
AstraZeneca Dividends
Dividend/share amount | Ex-dividend Date | Payment Date | Dividend Yield | |
---|---|---|---|---|
Next Dividend | £1.68 | 2/20/25 | 3/24/25 |
15.27%
14.66%
|
Last Dividend | £0.776 | 8/8/24 | 9/9/24 | 0.61% |
The next AstraZeneca dividend is expected in February, leave us your email to let you know.

AstraZeneca Dividend Calendar
Event | Day |
---|---|
Last trading date | February 19, 2025 |
Ex-date | February 20, 2025 |
Record date | February 21, 2025 |
Payable date | March 24, 2025 |
AstraZeneca dividend history
Ex-Date | Amount | Variation | Div. Yield |
---|---|---|---|
2024 | £233.6 | 0.43% | 2.06% |
8/8/24 | £77.6 | 0.61% | |
2/22/24 | £156 | 1.55% | |
2023 | £234.6 | 5.82% | 2.10% |
8/10/23 | £71.8 | 0.64% | |
2/23/23 | £162.8 | 1.45% | |
2022 | £221.7 | 9.64% | 2.32% |
8/11/22 | £76.4 | 0.73% | |
2/24/22 | £145.3 | 1.69% | |
2021 | £202.2 | 6.39% | 2.64% |
8/12/21 | £64.8 | 0.78% | |
2/25/21 | £137.4 | 1.96% | |
2020 | £216 | 1.23% | 2.75% |
8/13/20 | £69.6 | 0.81% | |
2/27/20 | £146.4 | 2.05% | |
2019 | £218.7 | 8.27% | 3.27% |
8/8/19 | £71.9 | 0.99% | |
2/28/19 | £146.8 | 2.39% | |
2018 | £202 | 7.80% | 3.74% |
8/9/18 | £68.4 | 1.13% | |
2/15/18 | £133.6 | 2.83% | |
2017 | £219.1 | 9.71% | 4.90% |
8/10/17 | £68.9 | 1.56% | |
2/16/17 | £150.2 | 3.32% | |
2016 | £199.7 | 9.42% | 4.30% |
8/11/16 | £68.7 | 1.33% | |
2/18/16 | £131 | 3.17% | |
2015 | £182.5 | 7.42% | 4.19% |
8/13/15 | £57.5 | 1.35% | |
2/19/15 | £125 | 2.82% | |
2014 | £169.9 | 5.45% | 4.20% |
8/13/14 | £53.1 | 1.29% | |
2/19/14 | £116.8 | 2.93% | |
2013 | £179.7 | 1.10% | 5.80% |
8/14/13 | £59.2 | 1.82% | |
2/13/13 | £120.5 | 4.08% | |
2012 | £181.7 | 7.77% | 6.15% |
8/8/12 | £58.1 | 1.93% | |
2/15/12 | £123.6 | 4.27% | |
2011 | £168.6 | 12.18% | 5.88% |
8/3/11 | £51.9 | 1.86% | |
2/2/11 | £116.7 | 3.96% | |
2010 | £150.3 | 6.75% | 4.96% |
8/4/10 | £44.9 | 1.39% | |
2/3/10 | £105.4 | 3.73% | |
2009 | £140.8 | 47.43% | 5.24% |
8/5/09 | £36 | 1.31% | |
2/4/09 | £104.8 | 4.00% | |
2008 | £95.5 | 8.15% | 4.18% |
8/6/08 | £27.8 | 1.09% | |
2/6/08 | £67.7 | 3.34% | |
2007 | £88.3 | 12.63% | 3.23% |
8/8/07 | £25.3 | 1.01% | |
2/7/07 | £63 | 2.14% | |
2006 | £78.4 | 39.50% | 2.68% |
8/9/06 | £26.6 | 0.83% | |
2/8/06 | £51.8 | 1.96% | |
2005 | £56.2 | 23.79% | 2.39% |
8/10/05 | £21.9 | 0.85% | |
2/9/05 | £34.3 | 1.62% | |
2004 | £45.4 | 3.30% | 1.85% |
8/11/04 | £16 | 0.67% | |
2/18/04 | £29.4 | 1.16% | |
2003 | £43.95 | 8.25% | 1.89% |
8/20/03 | £15.45 | 0.62% | |
2/19/03 | £28.5 | 1.33% | |
2002 | £47.9 | 0.71% | 1.77% |
8/21/02 | £14.7 | 0.75% | |
2/20/02 | £33.2 | 0.96% | |
2001 | £47.56 | 7.14% | 1.48% |
8/22/01 | £16.1 | 0.49% | |
2/21/01 | £31.46 | 1.00% | |
2000 | £44.39 | 5.19% | 1.68% |
9/4/00 | £15.29 | 0.49% | |
3/6/00 | £29.1 | 1.36% | |
1999 | £42.2 | 8.21% | 1.62% |
9/6/99 | £14.2 | 0.58% | |
3/29/99 | £28 | 1.01% | |
1998 | £39 | 8.33% | 1.63% |
9/14/98 | £14 | 0.62% | |
3/16/98 | £25 | 0.99% | |
1997 | £36 | 11.63% | 2.01% |
9/15/97 | £13.5 | 0.74% | |
3/17/97 | £22.5 | 1.29% | |
1996 | £32.25 | 11.21% | 2.27% |
9/16/96 | £12.5 | 0.83% | |
3/18/96 | £19.75 | 1.47% | |
1995 | £29 | 4.50% | 3.07% |
9/18/95 | £11.25 | 1.06% | |
3/13/95 | £17.75 | 2.16% | |
1994 | £27.75 | 164.29% | 3.64% |
9/12/94 | £10.75 | 1.34% | |
3/14/94 | £17 | 2.36% | |
1993 | £10.5 | 1.50% | |
9/20/93 | £10.5 | 1.50% |
AstraZeneca Dividend Analysis
AstraZeneca FAQ
AstraZeneca will reward its shareholders with a dividend of £1.68 per share, which represents a yield of 15.27%.
Those who are shareholders of AstraZeneca until February 19, 2025 will be eligible to receive £1.68 per share on March 24, 2025.
In the latest dividend distribution, AstraZeneca paid £0.776 per share on September 9, 2024 to shareholders who owned shares before August 8, 2024.
Investors in AstraZeneca can expect dividends in February and August, as part of its semiannual payment policy.
For AstraZeneca (AZN), the dividend yield last year stood at 2.06%, with an average of 2.38% over the last five years and 3.23% over the last ten years.
In the last fiscal year, AstraZeneca's payout ratio was 72.14%, indicating that profits adequately cover the dividend payment.
The dividend policy of AstraZeneca does not include increases in the short term.





